Author Correction: IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice
Yusuke Shintani(The University of Osaka), Ken Suzuki(Queen Mary University of London), Manabu Shiraishi(Queen Mary University of London), Yuki Ichihara(Queen Mary University of London), Hiroyuki Tanaka(Kurume University), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Nobuhiko Sato(Queen Mary University of London), Mihai Podaru(Queen Mary University of London), Laura Fields(Queen Mary University of London), T. Ito(Queen Mary University of London)
Cited by 0
Related Papers
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
|Frontiers in Cardiovascular Medicine|2022|106
IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice
|Scientific Reports|2017|105
Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study
|European Journal of Cardio-Thoracic Surgery|2016|89